BENGALURU : The life sciences division of Tata Consultancy Services (TCS) Ltd on Monday said that it is collaborating with the Council of Scientific and Industrial Research (CSIR) to design new chemical entities using artificial intelligence (AI) for treating the novel ‘Severe acute respiratory syndrome Coronavirus 2’ (SARS-CoV-2), the source of covid-19, which has severely affected the people and economy across the globe. “The TCS life sciences research area is engaged in cutting-edge application oriented research in synthetic biology.
De-novo drug candidate design is the first step in a long sequence of steps to find a cure to Covid-19. The collaboration between TCS and CSIR is a standing example of public private partnership in tackling